Cremolini, Chiara
Università di Pisa,
Italy
2025 Rank: 54908
Overall Rank
Rank in SubField 1
Publications
Citations
Main Field:
Clinical Medicine
SubField 1:
Oncology & Carcinogenesis
SubField 2:
Pharmacology & Pharmacy
Rank in SubField 1: 1665 out of 355674 Researchers
Data For The Year: 2025
| Metrics | Self-Citations Excluded | All |
|---|---|---|
| Rank Based on Composite Score | 54908 | 54557 |
| Total Cites | 2123 | 2379 |
| H-index | 20 | 22 |
| Hm-index | 4 | 5 |
| Number of Single Authored Papers | 2 | 2 |
| Total Cites to Single Authored Papers | 0 | 0 |
| Number of Single+First Authored Papers | 36 | 36 |
| Total Cites to Single+First Authored Papers | 329 | 355 |
| Number of Single+First+Last Authored Papers | 92 | 92 |
| Total Cites to Single+First+Last Authored Papers | 566 | 609 |
| Composite Score | 2 | 2 |
| Number of Distinct Citing Papers | 1387 | 1479 |
| Ratio of Total Citations to Distinct Citing Papers | 1.53 | 1.61 |
| Self-Citation Percentage |
10.76%
|
|
Cremolini, Chiara
Università di Pisa,
Italy
2024 Rank: 67542
Overall Rank
Rank in SubField 1
Publications
Citations
Main Field:
Clinical Medicine
SubField 1:
Oncology & Carcinogenesis
SubField 2:
Pharmacology & Pharmacy
Rank in SubField 1: 2197 out of 334837 Researchers
Data For The Year: 2024
| Metrics | Self-Citations Excluded | All |
|---|---|---|
| Rank Based on Composite Score | 67542 | 63079 |
| Total Cites | 1445 | 1658 |
| H-index | 18 | 19 |
| Hm-index | 4 | 4 |
| Number of Single Authored Papers | 2 | 2 |
| Total Cites to Single Authored Papers | 0 | 0 |
| Number of Single+First Authored Papers | 36 | 36 |
| Total Cites to Single+First Authored Papers | 330 | 371 |
| Number of Single+First+Last Authored Papers | 82 | 82 |
| Total Cites to Single+First+Last Authored Papers | 494 | 563 |
| Composite Score | 2 | 2 |
| Number of Distinct Citing Papers | 973 | 1051 |
| Ratio of Total Citations to Distinct Citing Papers | 1.49 | 1.58 |
| Self-Citation Percentage |
12.85%
|
|
Cremolini, Chiara
Università di Pisa,
Italy
2023 Rank: 55791
Overall Rank
Rank in SubField 1
Publications
Citations
Main Field:
Clinical Medicine
SubField 1:
Oncology & Carcinogenesis
SubField 2:
Pharmacology & Pharmacy
Rank in SubField 1: 1986 out of 312644 Researchers
Data For The Year: 2023
| Metrics | Self-Citations Excluded | All |
|---|---|---|
| Rank Based on Composite Score | 55791 | 51154 |
| Total Cites | 1341 | 1570 |
| H-index | 16 | 17 |
| Hm-index | 3 | 4 |
| Number of Single Authored Papers | 2 | 2 |
| Total Cites to Single Authored Papers | 2 | 2 |
| Number of Single+First Authored Papers | 35 | 35 |
| Total Cites to Single+First Authored Papers | 354 | 424 |
| Number of Single+First+Last Authored Papers | 72 | 72 |
| Total Cites to Single+First+Last Authored Papers | 483 | 581 |
| Composite Score | 2 | 2 |
| Number of Distinct Citing Papers | 919 | 984 |
| Ratio of Total Citations to Distinct Citing Papers | 1.46 | 1.60 |
| Self-Citation Percentage |
14.59%
|
|
Cremolini, Chiara
Azienda Ospedaliero Universitaria Pisana,
Italy
2022 Rank: 59754
Overall Rank
Rank in SubField 1
Publications
Citations
Main Field:
Clinical Medicine
SubField 1:
Oncology & Carcinogenesis
SubField 2:
Pharmacology & Pharmacy
Rank in SubField 1: 2267 out of 293195 Researchers
Data For The Year: 2022
| Metrics | Self-Citations Excluded | All |
|---|---|---|
| Rank Based on Composite Score | 59754 | 52367 |
| Total Cites | 1277 | 1499 |
| H-index | 17 | 19 |
| Hm-index | 3 | 4 |
| Number of Single Authored Papers | 2 | 2 |
| Total Cites to Single Authored Papers | 1 | 1 |
| Number of Single+First Authored Papers | 35 | 35 |
| Total Cites to Single+First Authored Papers | 362 | 430 |
| Number of Single+First+Last Authored Papers | 63 | 63 |
| Total Cites to Single+First+Last Authored Papers | 488 | 573 |
| Composite Score | 2 | 2 |
| Number of Distinct Citing Papers | 898 | 987 |
| Ratio of Total Citations to Distinct Citing Papers | 1.42 | 1.52 |
| Self-Citation Percentage |
14.81%
|
|
Cremolini, Chiara
Università di Pisa,
Italy
2021 Rank: 65734
Overall Rank
Rank in SubField 1
Publications
Citations
Main Field:
Clinical Medicine
SubField 1:
Oncology & Carcinogenesis
SubField 2:
Pharmacology & Pharmacy
Rank in SubField 1: 2383 out of 271773 Researchers
Data For The Year: 2021
| Metrics | Self-Citations Excluded | All |
|---|---|---|
| Rank Based on Composite Score | 65734 | 62540 |
| Total Cites | 1817 | 2118 |
| H-index | 22 | 23 |
| Hm-index | 4 | 4 |
| Number of Single Authored Papers | 1 | 1 |
| Total Cites to Single Authored Papers | 1 | 1 |
| Number of Single+First Authored Papers | 33 | 33 |
| Total Cites to Single+First Authored Papers | 517 | 610 |
| Number of Single+First+Last Authored Papers | 52 | 52 |
| Total Cites to Single+First+Last Authored Papers | 644 | 763 |
| Composite Score | 2 | 3 |
| Number of Distinct Citing Papers | 1271 | 1391 |
| Ratio of Total Citations to Distinct Citing Papers | 1.43 | 1.52 |
| Self-Citation Percentage |
14.21%
|
|
Cremolini, Chiara
Azienda Ospedaliera-Universitaria Pisana,
Italy
2020 Rank: 107957
Overall Rank
Rank in SubField 1
Publications
Citations
Main Field:
Clinical Medicine
SubField 1:
Oncology & Carcinogenesis
SubField 2:
Pharmacology & Pharmacy
Rank in SubField 1: 3754 out of 230678 Researchers
Data For The Year: 2020
| Metrics | Self-Citations Excluded | All |
|---|---|---|
| Rank Based on Composite Score | 107957 | 96269 |
| Total Cites | 1099 | 1301 |
| H-index | 17 | 19 |
| Hm-index | 2 | 3 |
| Number of Single Authored Papers | 1 | 1 |
| Total Cites to Single Authored Papers | 0 | 0 |
| Number of Single+First Authored Papers | 35 | 35 |
| Total Cites to Single+First Authored Papers | 306 | 352 |
| Number of Single+First+Last Authored Papers | 52 | 52 |
| Total Cites to Single+First+Last Authored Papers | 363 | 436 |
| Composite Score | 2 | 2 |
| Number of Distinct Citing Papers | 768 | 851 |
| Ratio of Total Citations to Distinct Citing Papers | 1.43 | 1.53 |
| Self-Citation Percentage |
15.53%
|
|
Partner with TOPSCINET
Reach science enthusiasts and researchers across the site. Write to business@topscinet.com and our marketing team will send a proposal built around your banner ad goals.